Back to Search
Start Over
Cost-Effectiveness of Unrelated Umbilical Cord Blood vs. HLA Haploidentical Related Bone Marrow Transplant: Evidence from BMT CTN 1101
- Source :
- Transplantation and Cellular Therapy; 20230101, Issue: Preprints
- Publication Year :
- 2023
-
Abstract
- •Haplo-bone marrow (BM) transplantation is moderately cost effective versus cord blood for persons under age 65 and cost-saving for those over 65.•Haplo-BM is a fair value choice for commercially insured patients with high-risk leukemia and lymphoma who require HCT.•For Medicare enrollees, haplo-BM is a preferred choice when considering costs and outcomes.
Details
- Language :
- English
- ISSN :
- 26666375 and 26666367
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Transplantation and Cellular Therapy
- Publication Type :
- Periodical
- Accession number :
- ejs62929312
- Full Text :
- https://doi.org/10.1016/j.jtct.2023.04.017